The hub DEMRGs-chemical interactions and the hub DEMRGs-drugs interactions were also analyzed, which demonstrated the chemicals and drugs of the targets, for instance, GNAI1, FLT1, and HCK that can be used to impede plaques progression and prevent MI recurrent events (Figure 4). This evidence concerns the gene GNAI1 and myocardial infarction.